Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
65
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer

Zhihui Chen1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
,
Weigang Dai1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
,
Liang Yang1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
,
Hong Yang2 Operating Department, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, People’s Republic of China
,
Li Ding3 Department of Pathology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
,
Yulong He1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
,
Xinming Song1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
&
Ji Cui1 Department of Gastrointestinal Surgery Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 4691-4697 | Published online: 23 May 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
  • Zhang L, Zhao J, Yu B, et al. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients. Cancer Genet. 2017;218–219:51–57. doi:10.1016/j.cancergen.2017.09.004
  • Meng H, Li W, Boardman LA, Wang L. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer. BMC Cancer. 2018;18(1):433. doi:10.1186/s12885-018-4242-829661177
  • Mizuno T, Cloyd JM, Vicente D, et al. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018;44(5):684–692. doi:10.1016/j.ejso.2018.02.24729551247
  • Letellier E, Schmitz M, Ginolhac A, et al. Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence. Br J Cancer. 2017;117(11):1689–1701. doi:10.1038/bjc.2017.35229024942
  • Abel S, Hundhausen C, Mentlein R, et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol. 2004;172:6362–6372. 15128827
  • Xing J, Liu Y, Chen T. Correlations of chemokine CXCL16 and TNF-α with coronary atherosclerotic heart disease. Exp Ther Med. 2018;15(1):773–776. doi:10.3892/etm.2017.545029399085
  • Ke C, Ren Y, Lv L, Hu W, Zhou W. Association between CXCL16/CXCR6 expression and the clinicopathological features of patients with non-small cell lung cancer. Oncol Lett. 2017;13(6):4661–4668. doi:10.3892/ol.2017.608828599467
  • Xiao G, Wang X, Wang J, et al. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms. Oncotarget. 2015;6(16):14165–14178. doi:10.18632/oncotarget.369025909173
  • Hattermann K, Bartsch K, Gebhardt HH, et al. “Inverse signaling” of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells. Cell Commun Signal. 2016;14(1):26. doi:10.1186/s12964-016-0149-727784296
  • Liu J, Chen S, Wang W, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Lett. 2016;379(1):49–59. 27216982
  • Xu K, Song X, Chen Z, Qin C, He Y, Zhan W. XRCC2 promotes colorectal cancer cell growth, regulates cell cycle progression, and apoptosis. Medicine (Baltimore). 2014;93(28):e294. doi:10.1097/MD.000000000000029425526472
  • Liang K, Liu Y, Eer D, Liu J, Yang F, Hu K. High CXC chemokine ligand 16 (CXCL16) expression promotes proliferation and metastasis of lung cancer via regulating the NF-κB pathway. Med Sci Monit. 2018;24:405–411. 29353287
  • Wang YH, Dong YY, Wang WM, et al. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013;32(1):51. doi:10.1186/1756-9966-32-5123941552
  • Chung B, Esmaeili AA, Gopalakrishna-Pillai S, et al. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. NPJ Breast Cancer. 2017;3:6. doi:10.1038/s41523-017-0008-828649646
  • Richardsen E, Ness N, Melbø-Jørgensen C, et al. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer. Am J Pathol. 2015;185(10):2722–2730. doi:10.1016/j.ajpath.2015.06.01326272362
  • Wågsäter D, Hugander A, Dimberg J. Expression of CXCL16 in human rectal cancer. Int J Mol Med. 2004;14(1):65–69. 15202017
  • Hojo S, Koizumi K, Tsuneyama K, et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res. 2007;67(10):4725–4731. doi:10.1158/0008-5472.CAN-06-342417510400
  • Kee JY, Ito A, Hojo S, et al. CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages. BMC Cancer. 2014;14:949. doi:10.1186/1471-2407-14-94925495942

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.